MC2288A1 - Systeme d'administration de medicament au niveau du colon - Google Patents

Systeme d'administration de medicament au niveau du colon

Info

Publication number
MC2288A1
MC2288A1 MC91@@D MC2288D MC2288A1 MC 2288 A1 MC2288 A1 MC 2288A1 MC 2288 D MC2288 D MC 2288D MC 2288 A1 MC2288 A1 MC 2288A1
Authority
MC
Monaco
Prior art keywords
colon
matrix
drug
drug administration
administration system
Prior art date
Application number
MC91@@D
Other languages
English (en)
French (fr)
Inventor
Amnon Sintov
Abraham Rubinstein
Original Assignee
Perio Prod Ltd
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24065163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC2288(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Perio Prod Ltd, Yissum Res Dev Co filed Critical Perio Prod Ltd
Publication of MC2288A1 publication Critical patent/MC2288A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0069—Chondroitin-4-sulfate, i.e. chondroitin sulfate A; Dermatan sulfate, i.e. chondroitin sulfate B or beta-heparin; Chondroitin-6-sulfate, i.e. chondroitin sulfate C; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0045—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Galacturonans, e.g. methyl ester of (alpha-1,4)-linked D-galacturonic acid units, i.e. pectin, or hydrolysis product of methyl ester of alpha-1,4-linked D-galacturonic acid units, i.e. pectinic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Percussion Or Vibration Massage (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Surgical Instruments (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Memory System Of A Hierarchy Structure (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
MC91@@D 1990-05-04 1991-05-02 Systeme d'administration de medicament au niveau du colon MC2288A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51871490A 1990-05-04 1990-05-04
PCT/US1991/003014 WO1991016881A1 (en) 1990-05-04 1991-05-02 Colonic drug delivery system

Publications (1)

Publication Number Publication Date
MC2288A1 true MC2288A1 (fr) 1993-07-14

Family

ID=24065163

Family Applications (1)

Application Number Title Priority Date Filing Date
MC91@@D MC2288A1 (fr) 1990-05-04 1991-05-02 Systeme d'administration de medicament au niveau du colon

Country Status (17)

Country Link
EP (1) EP0527942B1 (de)
JP (1) JPH05508631A (de)
KR (1) KR100194161B1 (de)
AT (1) ATE185267T1 (de)
AU (1) AU660147B2 (de)
BR (1) BR9106419A (de)
CA (1) CA2082156A1 (de)
DE (2) DE527942T1 (de)
DK (1) DK0527942T3 (de)
ES (1) ES2048133T3 (de)
FI (1) FI924984A0 (de)
GR (2) GR940300025T1 (de)
HU (1) HU210497B (de)
MC (1) MC2288A1 (de)
NO (1) NO306096B1 (de)
RU (1) RU2113221C1 (de)
WO (1) WO1991016881A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4209160A1 (de) * 1992-03-20 1993-09-30 Bauer Kurt Heinz Prof Dr Vernetzte Polysaccharide, Verfahren zu ihrer Herstellung und ihre Verwendung
US5656290A (en) * 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
AU695906B2 (en) * 1993-11-17 1998-08-27 Commonwealth Scientific And Industrial Research Organisation Fatty acid delivery system
US5840860A (en) * 1993-11-17 1998-11-24 Commonwealth Scientific And Industrial Research Organization Fatty acid delivery system comprising a hydrolyzable bond
DE4340057A1 (de) * 1993-11-24 1995-06-01 Falk Pharma Gmbh Budesonid-Arzneimittel zur Verbesserung der enteralen Flüssigkeitsresorption, insbesondere nach postoperativen Zuständen
EP0759303B1 (de) 1994-04-22 2002-10-16 Yamanouchi Pharmaceutical Co. Ltd. Kolon-spezifisches arzneistofffreisetzungssystem
US5849327A (en) * 1994-07-29 1998-12-15 Advanced Polymer Systems, Inc. Delivery of drugs to the lower gastrointestinal tract
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
US5656294A (en) * 1995-06-07 1997-08-12 Cibus Pharmaceutical, Inc. Colonic delivery of drugs
GB9516268D0 (en) 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
AU710109B2 (en) * 1996-01-16 1999-09-16 Ap Pharma, Inc. Topical delivery of drugs to the lower gastrointestinal tract
FR2752843B1 (fr) * 1996-08-30 1998-10-16 Sod Conseils Rech Applic Copolymeres reticules a base de polymeres polycarboxyliques et leur utilisation comme support de composition pharmaceutique
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US6229009B1 (en) 1997-08-29 2001-05-08 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Polycarboxylic based cross-linked copolymers
US6187330B1 (en) 1998-01-30 2001-02-13 Scios Inc. Controlled release delivery of peptide or protein
KR20000011247A (ko) * 1998-07-23 2000-02-25 김윤 다당류를이용한대장선택성약물전달조성물및약학제제
IT1303735B1 (it) * 1998-11-11 2001-02-23 Falorni Italia Farmaceutici S Acidi ialuronici reticolati e loro usi medici.
IT1303738B1 (it) * 1998-11-11 2001-02-23 Aquisitio S P A Processo di reticolazione di polisaccaridi carbossilati.
ATE314091T1 (de) 1999-06-09 2006-01-15 Mochida Pharm Co Ltd System für wirkstofffreisetzung im unteren verdauungstrakt
FR2799196B1 (fr) * 1999-10-04 2002-02-08 Sod Conseils Rech Applic Copolymeres reticules a base de copolymeres polycarboxyliques non reticules
US20060110517A1 (en) * 2003-01-31 2006-05-25 Reinhold Carle Novel compositions comprising carotenoids
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
KR101122845B1 (ko) 2009-07-30 2012-03-21 부산대학교 산학협력단 경구용 염증성 장질환 치료제
AU2013240289B2 (en) 2012-03-29 2018-01-25 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
NZ711298A (en) 2013-03-14 2021-07-30 Therabiome Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
JP6110037B2 (ja) * 2015-01-16 2017-04-05 生化学工業株式会社 コンドロイチン硫酸架橋体、並びにこれを含有する組成物、及び眼疾患処置剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7504049L (sv) * 1975-04-09 1976-10-10 Haessle Ab Colonpreparation
DE2717707C3 (de) * 1977-04-21 1979-11-22 Chephasaar Chemisch-Pharmazeutische Fabrik Gmbh, 6670 St Ingbert Karamellisierte Lactulose
US4668517A (en) * 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
ZA881301B (en) * 1987-02-27 1989-10-25 Lilly Co Eli Sustained release matrix formulations
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
US4857331A (en) * 1988-03-31 1989-08-15 Warner-Lambert Company Sugarless pectin delivery system
IT1219942B (it) * 1988-05-13 1990-05-24 Fidia Farmaceutici Esteri polisaccaridici
DE4006521A1 (de) * 1990-03-02 1991-09-05 Bayer Ag Zuckerhaltige polymere zur umhuellung und einbettung von arzneistoffen

Also Published As

Publication number Publication date
ES2048133T3 (es) 2000-01-16
ATE185267T1 (de) 1999-10-15
WO1991016881A1 (en) 1991-11-14
FI924984A (fi) 1992-11-04
DK0527942T3 (da) 2000-03-27
CA2082156A1 (en) 1991-11-05
HU9203451D0 (en) 1993-05-28
HU210497B (en) 1995-04-28
GR3031906T3 (en) 2000-02-29
GR940300025T1 (de) 1994-05-31
RU2113221C1 (ru) 1998-06-20
NO924227D0 (no) 1992-11-03
EP0527942A4 (en) 1993-10-13
AU8087791A (en) 1991-11-27
ES2048133T1 (es) 1994-03-16
DE527942T1 (de) 1994-03-03
NO306096B1 (no) 1999-09-20
KR100194161B1 (ko) 1999-06-15
EP0527942A1 (de) 1993-02-24
JPH05508631A (ja) 1993-12-02
NO924227L (no) 1992-12-30
DE69131688T2 (de) 2000-05-25
HUT64210A (en) 1993-12-28
DE69131688D1 (de) 1999-11-11
AU660147B2 (en) 1995-06-15
FI924984A0 (fi) 1992-11-04
BR9106419A (pt) 1993-05-04
EP0527942B1 (de) 1999-10-06

Similar Documents

Publication Publication Date Title
MC2288A1 (fr) Systeme d'administration de medicament au niveau du colon
NO20015584L (no) Langtidsvarende insulintropiske peptider og konjugater samt anvendelse for fremstilling av medikamenter for behandling
NZ262679A (en) Compositions for in vivo delivery of pharmaceutical agents where the agents are contained in a polymeric shell
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
DE69637961D1 (de) Verabreichung von biologisch aktiven polypeptiden
CY1105707T1 (el) Συνδυασμοι φορμοτερολης και ενος αλατος τριοτροπιου
HUT43948A (en) Emulsion compositions for dosing ionizable hydrophobic medical substances which are little soluble in water and process for preparing the same
FI920206A0 (fi) Medicinsk anvaendning, medicinskt foerfarande och preparat.
DK0686034T3 (da) Bisacodyl-doseringsform
CN108325054A (zh) 胃肠道感染腔内治疗系统
DK0615444T3 (da) Peroral indgivelsesform til peptidlægemidler, især insulin
AU2014282802B2 (en) Pharmaceutical formulations and methods for oral delivery of biologically active ingredient
Barkade et al. Insulin Tablet Novel Strategy for Diabetes Management
TH57760B (th) การลำเลียงยาสู่ลำไส้เล็กและลำไส้ใหญ่โดยใช้แคปซูลชนิด hpmc
RU94024117A (ru) Способ лечения гастроэнтероколита
CO4130184A1 (es) Forma de dosificacion de bisacodyl
RU96119817A (ru) Способ лечения дисбактериозов кишечника
TW357092B (en) Transport of solid medicament components
RU2002135755A (ru) Способ защиты дыхательного центра пациента при тяжёлых механических травмах
RU95118193A (ru) Штамм бактерий bifidobacterium coturnix, используемый для приготовления пробиотического препарата для птицеводства и ветеринарии
IT1254688B (it) Composizioni farmaceutiche somministrabili per via orale a rilascio mirato contenenti acido ursodesossicolico ed acido chenodesossicolico.
RU98109592A (ru) Применение белка s-100b в лекарственных средствах и лекарственные средства, содержащие белок s-100b
UA10110A (uk) Спосіб лікування сполучних уражень органів дихання і травлення у дітей
JP2006151870A5 (de)
UA22223A (uk) Спосіб лікуваhhя захворюваhь оргаhа зору